141 related articles for article (PubMed ID: 2214880)
21. Long-term low dose interferon alpha-2b in the treatment of chronic hepatitis B in multi-ethnic patients in Hawaii.
Ching N; Lumeng J; Pang R; Pang G; Or FW; Ching N; Ching C
Hawaii Med J; 1996 Oct; 55(10):201-3. PubMed ID: 8942117
[TBL] [Abstract][Full Text] [Related]
22. [Long term study of the treatment with recombinant alfa 2b interferon in chronic active hepatitis due to B virus in children and adolescents].
Castañeda Guillot C; Escobar Capote MD; García Bacallao E; Borbolla Bousquets E
G E N; 1994; 48(4):219-25. PubMed ID: 7557276
[TBL] [Abstract][Full Text] [Related]
23. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
Lau GK; Piratvisuth T; Luo KX; Marcellin P; Thongsawat S; Cooksley G; Gane E; Fried MW; Chow WC; Paik SW; Chang WY; Berg T; Flisiak R; McCloud P; Pluck N;
N Engl J Med; 2005 Jun; 352(26):2682-95. PubMed ID: 15987917
[TBL] [Abstract][Full Text] [Related]
24. Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus.
Perrillo R; Tamburro C; Regenstein F; Balart L; Bodenheimer H; Silva M; Schiff E; Bodicky C; Miller B; Denham C
Gastroenterology; 1995 Sep; 109(3):908-16. PubMed ID: 7657121
[TBL] [Abstract][Full Text] [Related]
25. Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B.
Hoofnagle JH; Peters M; Mullen KD; Jones DB; Rustgi V; Di Bisceglie A; Hallahan C; Park Y; Meschievitz C; Jones EA
Gastroenterology; 1988 Nov; 95(5):1318-25. PubMed ID: 3049216
[TBL] [Abstract][Full Text] [Related]
26. Comparative study of three doses of interferon-alpha 2a in chronic active hepatitis B. The International Hepatitis Trial Group.
Thomas HC; Lok AS; Carreño V; Farrell G; Tanno H; Perez V; Dusheiko GM; Cooksley G; Ryff JC
J Viral Hepat; 1994; 1(2):139-48. PubMed ID: 8790569
[TBL] [Abstract][Full Text] [Related]
27. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
[TBL] [Abstract][Full Text] [Related]
28. Treatment with interferon gamma versus interferons alfa and gamma in children with chronic hepatitis B.
Ruiz-Moreno M; Rúa MJ; Moraleda G; Guardia L; Moreno A; Carreño V
Pediatrics; 1992 Aug; 90(2 Pt 1):254-8. PubMed ID: 1641292
[TBL] [Abstract][Full Text] [Related]
29. Low dose alpha interferon treatment in chronic hepatitis B virus infection.
Müller R; Baumgarten R; Markus R; Schulz M; Wittenberg H; Hintsche-Kilger B; Fengler JD; von Wussow P; Meisel H; Klein H
Gut; 1993; 34(2 Suppl):S97-8. PubMed ID: 8314499
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of patients with chronic hepatitis B after interferon treatment.
Teuber G; Dienes HP; Meyer Zum Büschenfelde KH; Gerken G
Z Gastroenterol; 1996 Apr; 34(4):230-6. PubMed ID: 8686350
[TBL] [Abstract][Full Text] [Related]
31. A multicentre randomized clinical trial of recombinant alpha-2a interferon therapy in patients with chronic hepatitis B.
Rumi M; Romeo R; De Filippi F; Marcelli R; Del Ninno E; van Eyken P; Desmet V; Colombo M
Ital J Gastroenterol; 1993 Apr; 25(3):117-20. PubMed ID: 8507888
[TBL] [Abstract][Full Text] [Related]
32. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
[TBL] [Abstract][Full Text] [Related]
33. [Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B].
Janssen HL; Berk L; de Man RA; Heijtink RA; Schalm SW
Ned Tijdschr Geneeskd; 1992 Apr; 136(17):835-9. PubMed ID: 1522928
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of interferon alpha-2b following prednisone withdrawal in the treatment of chronic viral hepatitis B. A case-controlled, randomised study.
Robson SC; Brice E; van Rensburg C; Kannemeyer J; Hift RJ; Kirsch RE
S Afr Med J; 1992 Nov; 82(5):317-20. PubMed ID: 1448711
[TBL] [Abstract][Full Text] [Related]
35. Persistent hepatitis B virus following interferon alfa therapy and liver transplantation.
Lavine JE; Lake JR; Ascher NL; Ferrell LD; Ganem D; Wright TL
Gastroenterology; 1991 Jan; 100(1):263-7. PubMed ID: 1983831
[TBL] [Abstract][Full Text] [Related]
36. Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.
Brook MG; McDonald JA; Karayiannis P; Caruso L; Forster G; Harris JR; Thomas HC
Gut; 1989 Aug; 30(8):1116-22. PubMed ID: 2670693
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of chronic viral hepatitis B in children with moderate doses of alpha interferon].
Cullu F; Tümay GT; Kutlu T; Erkan T; Ozbay G; Badur S
Gastroenterol Clin Biol; 1995 Jan; 19(1):53-7. PubMed ID: 7720991
[TBL] [Abstract][Full Text] [Related]
38. Pilot study of recombinant human alpha-interferon for chronic type B hepatitis.
Dooley JS; Davis GL; Peters M; Waggoner JG; Goodman Z; Hoofnagle JH
Gastroenterology; 1986 Jan; 90(1):150-7. PubMed ID: 3940241
[TBL] [Abstract][Full Text] [Related]
39. Interferon for hepatitis B: US experience.
Perrillo RP
Gut; 1993; 34(2 Suppl):S95-6. PubMed ID: 8314498
[TBL] [Abstract][Full Text] [Related]
40. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.
Perrillo RP; Schiff ER; Davis GL; Bodenheimer HC; Lindsay K; Payne J; Dienstag JL; O'Brien C; Tamburro C; Jacobson IM; Sampliner R; Feit D; Lefkowitch J; Kuhns M; Meschievitz C; Sanghvi B; Albrecht J; Gibas A;
N Engl J Med; 1990 Aug; 323(5):295-301. PubMed ID: 2195346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
